INTERNATIONAL PATENT: CELCUITY INC. FILES APPLICATION FOR "TREATMENT OF OCULAR DISEASES USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL)PHENYL)-3-[4-(4,6- DIMORPHOLIN-4- YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA"

GENEVA, June 25 -- CELCUITY INC. (16305 36th Ave N. Ste 100Minneapolis, MN 55446) filed a patent application (PCT/US2024/059586) for "TREATMENT OF OCULAR DISEASES USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL)PHENYL)-3-[4-(4,6- DIMORPHOLIN-4- YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA" on Dec 11, 2024. With publication no. WO/2025/128712, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAING, Lance, Gavin (16305 36th Ave N. Ste 100Minneapolis, MN 55446), MACNEIL, Ian (23 Oak RoadMilton, MA 02186), SULLIVAN, Brian, Francis ...